Last edition
News about " acquisition of select business divisions of Wockh"
Glenmark Launches Lacosamide Injection USP, 200 mg/20 mL (10 mg/mL), Single-Dose Vials
Glenmark Pharmaceuticals Inc., USA has launched Lacosamide Injection USP, 200 mg/20 mL (10 mg/mL), a bioequivalent and therapeutically equivalent generic version of Vimpat Injection.
Acquisition Of Select Business Divisions Of Wockh | 05/06/2026 | By News Bureau
Dr. Reddy's Labs completes acquisition of select business divisions of Wockhardt
Dr. Reddy's Laboratories Ltd announced that it has completed the acquisition of select divisions of Wockhardt Limited's branded generics business in India and a few other international territories of Nepal, Sri Lanka, Bhutan and Maldives
Acquisition Of Select Business Divisions Of Wockh | 10/06/2020 | By Darshana | 725
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy